Lexogen GmbH

Lexogen and our team is growing bigger day by day and so are our offices! We are excited to greet you in our new space ;) Drop by to say hello!

We are proud to announce the launch of a pioneering, ultra-high-throughput SARS-CoV-2 test that for the first time enables a true mass screening of the whole population.
Lexogen’s unique solution can be implemented in any work environment and allows for regular testing of millions of people in 24 hours.
This unique mass screening assay is based on industry-leading and widely employed sequencing technology. It is currently the fastest method available on the market, which also significantly reduces the amounts of consumables needed, making it an economically viable solution for a Public Health strategic implementation.

Find more in our official press release: https://www.lexogen.com/launch-covid-19-ultra-high-throughput-test/